Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W2087176118', 'doi': 'https://doi.org/10.1038/mt.2011.271', 'title': 'Co-administration With the Pharmacological Chaperone AT1001 Increases Recombinant Human α-Galactosidase A Tissue Uptake and Improves Substrate Reduction in Fabry Mice', 'display_name': 'Co-administration With the Pharmacological Chaperone AT1001 Increases Recombinant Human α-Galactosidase A Tissue Uptake and Improves Substrate Reduction in Fabry Mice', 'publication_year': 2012, 'publication_date': '2012-01-03', 'ids': {'openalex': 'https://openalex.org/W2087176118', 'doi': 'https://doi.org/10.1038/mt.2011.271', 'mag': '2087176118', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/22215019', 'pmcid': 'https://www.ncbi.nlm.nih.gov/pmc/articles/3321591'}, 'language': 'en', 'primary_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1038/mt.2011.271', 'pdf_url': 'http://www.cell.com/article/S1525001616305366/pdf', 'source': {'id': 'https://openalex.org/S51596929', 'display_name': 'Molecular Therapy', 'issn_l': '1525-0016', 'issn': ['1525-0016', '1525-0024'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320990', 'host_organization_name': 'Elsevier BV', 'host_organization_lineage': ['https://openalex.org/P4310320990'], 'host_organization_lineage_names': ['Elsevier BV'], 'type': 'journal'}, 'license': 'cc-by-nc-nd', 'license_id': 'https://openalex.org/licenses/cc-by-nc-nd', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': True, 'oa_status': 'hybrid', 'oa_url': 'http://www.cell.com/article/S1525001616305366/pdf', 'any_repository_has_fulltext': True}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5088971653', 'display_name': 'Benjamin Elias', 'orcid': 'https://orcid.org/0000-0001-5037-3313'}, 'institutions': [{'id': 'https://openalex.org/I1306559669', 'display_name': 'Amicus Therapeutics (United Kingdom)', 'ror': 'https://ror.org/05n451y37', 'country_code': 'GB', 'type': 'company', 'lineage': ['https://openalex.org/I1306559669', 'https://openalex.org/I4210134439']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Elfrida R Benjamin', 'raw_affiliation_strings': ['Amicus Therapeutics Inc., Cranbury, New Jersey 08512, USA.'], 'affiliations': [{'raw_affiliation_string': 'Amicus Therapeutics Inc., Cranbury, New Jersey 08512, USA.', 'institution_ids': ['https://openalex.org/I1306559669']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5104623070', 'display_name': 'Richie Khanna', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1306559669', 'display_name': 'Amicus Therapeutics (United Kingdom)', 'ror': 'https://ror.org/05n451y37', 'country_code': 'GB', 'type': 'company', 'lineage': ['https://openalex.org/I1306559669', 'https://openalex.org/I4210134439']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Richie Khanna', 'raw_affiliation_strings': ['Amicus Therapeutics, Inc., Cranbury, New Jersey, USA.'], 'affiliations': [{'raw_affiliation_string': 'Amicus Therapeutics, Inc., Cranbury, New Jersey, USA.', 'institution_ids': ['https://openalex.org/I1306559669']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5015338081', 'display_name': 'Adriane Schilling', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1306559669', 'display_name': 'Amicus Therapeutics (United Kingdom)', 'ror': 'https://ror.org/05n451y37', 'country_code': 'GB', 'type': 'company', 'lineage': ['https://openalex.org/I1306559669', 'https://openalex.org/I4210134439']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Adriane Schilling', 'raw_affiliation_strings': ['Amicus Therapeutics, Inc., Cranbury, New Jersey, USA.'], 'affiliations': [{'raw_affiliation_string': 'Amicus Therapeutics, Inc., Cranbury, New Jersey, USA.', 'institution_ids': ['https://openalex.org/I1306559669']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5059577497', 'display_name': 'John J. Flanagan', 'orcid': 'https://orcid.org/0000-0001-7118-0940'}, 'institutions': [{'id': 'https://openalex.org/I1306559669', 'display_name': 'Amicus Therapeutics (United Kingdom)', 'ror': 'https://ror.org/05n451y37', 'country_code': 'GB', 'type': 'company', 'lineage': ['https://openalex.org/I1306559669', 'https://openalex.org/I4210134439']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'John J Flanagan', 'raw_affiliation_strings': ['Amicus Therapeutics, Inc., Cranbury, New Jersey, USA.'], 'affiliations': [{'raw_affiliation_string': 'Amicus Therapeutics, Inc., Cranbury, New Jersey, USA.', 'institution_ids': ['https://openalex.org/I1306559669']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5103512418', 'display_name': 'Lee Pellegrino', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1306559669', 'display_name': 'Amicus Therapeutics (United Kingdom)', 'ror': 'https://ror.org/05n451y37', 'country_code': 'GB', 'type': 'company', 'lineage': ['https://openalex.org/I1306559669', 'https://openalex.org/I4210134439']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Lee J Pellegrino', 'raw_affiliation_strings': ['Amicus Therapeutics, Inc., Cranbury, New Jersey, USA.'], 'affiliations': [{'raw_affiliation_string': 'Amicus Therapeutics, Inc., Cranbury, New Jersey, USA.', 'institution_ids': ['https://openalex.org/I1306559669']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5051530258', 'display_name': 'Nastry Brignol', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1306559669', 'display_name': 'Amicus Therapeutics (United Kingdom)', 'ror': 'https://ror.org/05n451y37', 'country_code': 'GB', 'type': 'company', 'lineage': ['https://openalex.org/I1306559669', 'https://openalex.org/I4210134439']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Nastry Brignol', 'raw_affiliation_strings': ['Amicus Therapeutics, Inc., Cranbury, New Jersey, USA.'], 'affiliations': [{'raw_affiliation_string': 'Amicus Therapeutics, Inc., Cranbury, New Jersey, USA.', 'institution_ids': ['https://openalex.org/I1306559669']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5100831991', 'display_name': 'Yi Lun', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1306559669', 'display_name': 'Amicus Therapeutics (United Kingdom)', 'ror': 'https://ror.org/05n451y37', 'country_code': 'GB', 'type': 'company', 'lineage': ['https://openalex.org/I1306559669', 'https://openalex.org/I4210134439']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Yi Lun', 'raw_affiliation_strings': ['Amicus Therapeutics, Inc., Cranbury, New Jersey, USA.'], 'affiliations': [{'raw_affiliation_string': 'Amicus Therapeutics, Inc., Cranbury, New Jersey, USA.', 'institution_ids': ['https://openalex.org/I1306559669']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5070899844', 'display_name': 'Darlene Guillen', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1306559669', 'display_name': 'Amicus Therapeutics (United Kingdom)', 'ror': 'https://ror.org/05n451y37', 'country_code': 'GB', 'type': 'company', 'lineage': ['https://openalex.org/I1306559669', 'https://openalex.org/I4210134439']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Darlene Guillen', 'raw_affiliation_strings': ['Amicus Therapeutics, Inc., Cranbury, New Jersey, USA.'], 'affiliations': [{'raw_affiliation_string': 'Amicus Therapeutics, Inc., Cranbury, New Jersey, USA.', 'institution_ids': ['https://openalex.org/I1306559669']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5021777888', 'display_name': 'Brian Ranes', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1306559669', 'display_name': 'Amicus Therapeutics (United Kingdom)', 'ror': 'https://ror.org/05n451y37', 'country_code': 'GB', 'type': 'company', 'lineage': ['https://openalex.org/I1306559669', 'https://openalex.org/I4210134439']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Brian E Ranes', 'raw_affiliation_strings': ['Amicus Therapeutics, Inc., Cranbury, New Jersey, USA.'], 'affiliations': [{'raw_affiliation_string': 'Amicus Therapeutics, Inc., Cranbury, New Jersey, USA.', 'institution_ids': ['https://openalex.org/I1306559669']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5003778691', 'display_name': 'Michelle Frascella', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1306559669', 'display_name': 'Amicus Therapeutics (United Kingdom)', 'ror': 'https://ror.org/05n451y37', 'country_code': 'GB', 'type': 'company', 'lineage': ['https://openalex.org/I1306559669', 'https://openalex.org/I4210134439']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Michelle Frascella', 'raw_affiliation_strings': ['Amicus Therapeutics, Inc., Cranbury, New Jersey, USA.'], 'affiliations': [{'raw_affiliation_string': 'Amicus Therapeutics, Inc., Cranbury, New Jersey, USA.', 'institution_ids': ['https://openalex.org/I1306559669']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5019427228', 'display_name': 'Rebecca Soska', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1306559669', 'display_name': 'Amicus Therapeutics (United Kingdom)', 'ror': 'https://ror.org/05n451y37', 'country_code': 'GB', 'type': 'company', 'lineage': ['https://openalex.org/I1306559669', 'https://openalex.org/I4210134439']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Rebecca Soska', 'raw_affiliation_strings': ['Amicus Therapeutics, Inc., Cranbury, New Jersey, USA.'], 'affiliations': [{'raw_affiliation_string': 'Amicus Therapeutics, Inc., Cranbury, New Jersey, USA.', 'institution_ids': ['https://openalex.org/I1306559669']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5103436960', 'display_name': 'Jessie Feng', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1306559669', 'display_name': 'Amicus Therapeutics (United Kingdom)', 'ror': 'https://ror.org/05n451y37', 'country_code': 'GB', 'type': 'company', 'lineage': ['https://openalex.org/I1306559669', 'https://openalex.org/I4210134439']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Jessie Feng', 'raw_affiliation_strings': ['Amicus Therapeutics, Inc., Cranbury, New Jersey, USA.'], 'affiliations': [{'raw_affiliation_string': 'Amicus Therapeutics, Inc., Cranbury, New Jersey, USA.', 'institution_ids': ['https://openalex.org/I1306559669']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5063966868', 'display_name': 'Leo B. Dungan', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1306559669', 'display_name': 'Amicus Therapeutics (United Kingdom)', 'ror': 'https://ror.org/05n451y37', 'country_code': 'GB', 'type': 'company', 'lineage': ['https://openalex.org/I1306559669', 'https://openalex.org/I4210134439']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Leo Dungan', 'raw_affiliation_strings': ['Amicus Therapeutics, Inc., Cranbury, New Jersey, USA.'], 'affiliations': [{'raw_affiliation_string': 'Amicus Therapeutics, Inc., Cranbury, New Jersey, USA.', 'institution_ids': ['https://openalex.org/I1306559669']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5060777158', 'display_name': 'Brandy Young', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I157614274', 'display_name': 'University of Cape Town', 'ror': 'https://ror.org/03p74gp79', 'country_code': 'ZA', 'type': 'education', 'lineage': ['https://openalex.org/I157614274']}], 'countries': ['ZA'], 'is_corresponding': False, 'raw_author_name': 'Brandy Young', 'raw_affiliation_strings': ['University of Capetown, Faculty of Health Sciences, Medical Biochemistry, Capetown, South Africa'], 'affiliations': [{'raw_affiliation_string': 'University of Capetown, Faculty of Health Sciences, Medical Biochemistry, Capetown, South Africa', 'institution_ids': ['https://openalex.org/I157614274']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5036564166', 'display_name': 'David J. Lockhart', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1306559669', 'display_name': 'Amicus Therapeutics (United Kingdom)', 'ror': 'https://ror.org/05n451y37', 'country_code': 'GB', 'type': 'company', 'lineage': ['https://openalex.org/I1306559669', 'https://openalex.org/I4210134439']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'David J Lockhart', 'raw_affiliation_strings': ['Amicus Therapeutics, Inc., Cranbury, New Jersey, USA.'], 'affiliations': [{'raw_affiliation_string': 'Amicus Therapeutics, Inc., Cranbury, New Jersey, USA.', 'institution_ids': ['https://openalex.org/I1306559669']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5035296804', 'display_name': 'Kenneth J. Valenzano', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1306559669', 'display_name': 'Amicus Therapeutics (United Kingdom)', 'ror': 'https://ror.org/05n451y37', 'country_code': 'GB', 'type': 'company', 'lineage': ['https://openalex.org/I1306559669', 'https://openalex.org/I4210134439']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Kenneth J Valenzano', 'raw_affiliation_strings': ['Amicus Therapeutics, Inc., Cranbury, New Jersey, USA.'], 'affiliations': [{'raw_affiliation_string': 'Amicus Therapeutics, Inc., Cranbury, New Jersey, USA.', 'institution_ids': ['https://openalex.org/I1306559669']}]}], 'institution_assertions': [], 'countries_distinct_count': 2, 'institutions_distinct_count': 2, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': {'value': 3900, 'currency': 'USD', 'value_usd': 3900, 'provenance': 'doaj'}, 'apc_paid': {'value': 3900, 'currency': 'USD', 'value_usd': 3900, 'provenance': 'doaj'}, 'fwci': 7.605, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 86, 'citation_normalized_percentile': {'value': 0.999948, 'is_in_top_1_percent': True, 'is_in_top_10_percent': True}, 'cited_by_percentile_year': {'min': 97, 'max': 98}, 'biblio': {'volume': '20', 'issue': '4', 'first_page': '717', 'last_page': '726'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10945', 'display_name': 'Lysosomal Storage Disorders in Human Health and Disease', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2737', 'display_name': 'Physiology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10945', 'display_name': 'Lysosomal Storage Disorders in Human Health and Disease', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2737', 'display_name': 'Physiology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10890', 'display_name': 'Epidemiology and Treatment of Chagas Disease', 'score': 0.9793, 'subfield': {'id': 'https://openalex.org/subfields/2713', 'display_name': 'Epidemiology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T14415', 'display_name': 'Nephropathic Cystinosis Research', 'score': 0.9787, 'subfield': {'id': 'https://openalex.org/subfields/2734', 'display_name': 'Pathology and Forensic Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/alpha-galactosidase', 'display_name': 'Alpha-galactosidase', 'score': 0.92058104}, {'id': 'https://openalex.org/keywords/globotriaosylceramide', 'display_name': 'Globotriaosylceramide', 'score': 0.89182276}, {'id': 'https://openalex.org/keywords/lysosomal-storage-disease', 'display_name': 'Lysosomal storage disease', 'score': 0.67509764}, {'id': 'https://openalex.org/keywords/fabry-disease', 'display_name': 'Fabry Disease', 'score': 0.518869}, {'id': 'https://openalex.org/keywords/hydrolase', 'display_name': 'Hydrolase', 'score': 0.51111895}, {'id': 'https://openalex.org/keywords/substrate-reduction-therapy', 'display_name': 'Substrate reduction therapy', 'score': 0.4120317}], 'concepts': [{'id': 'https://openalex.org/C2777404818', 'wikidata': 'https://www.wikidata.org/wiki/Q615645', 'display_name': 'Fabry disease', 'level': 3, 'score': 0.92950255}, {'id': 'https://openalex.org/C2776788019', 'wikidata': 'https://www.wikidata.org/wiki/Q83170235', 'display_name': 'Alpha-galactosidase', 'level': 4, 'score': 0.92058104}, {'id': 'https://openalex.org/C2777687718', 'wikidata': 'https://www.wikidata.org/wiki/Q410539', 'display_name': 'Globotriaosylceramide', 'level': 4, 'score': 0.89182276}, {'id': 'https://openalex.org/C2778264360', 'wikidata': 'https://www.wikidata.org/wiki/Q675010', 'display_name': 'Lysosomal storage disease', 'level': 3, 'score': 0.67509764}, {'id': 'https://openalex.org/C2779969927', 'wikidata': 'https://www.wikidata.org/wiki/Q916766', 'display_name': 'Enzyme replacement therapy', 'level': 3, 'score': 0.56902933}, {'id': 'https://openalex.org/C40767141', 'wikidata': 'https://www.wikidata.org/wiki/Q285697', 'display_name': 'Recombinant DNA', 'level': 3, 'score': 0.54514027}, {'id': 'https://openalex.org/C185592680', 'wikidata': 'https://www.wikidata.org/wiki/Q2329', 'display_name': 'Chemistry', 'level': 0, 'score': 0.5328252}, {'id': 'https://openalex.org/C153911025', 'wikidata': 'https://www.wikidata.org/wiki/Q7202', 'display_name': 'Molecular biology', 'level': 1, 'score': 0.5299253}, {'id': 'https://openalex.org/C2780120296', 'wikidata': 'https://www.wikidata.org/wiki/Q96286', 'display_name': 'Hydrolase', 'level': 3, 'score': 0.51111895}, {'id': 'https://openalex.org/C181199279', 'wikidata': 'https://www.wikidata.org/wiki/Q8047', 'display_name': 'Enzyme', 'level': 2, 'score': 0.50411403}, {'id': 'https://openalex.org/C21850170', 'wikidata': 'https://www.wikidata.org/wiki/Q1406265', 'display_name': 'Substrate reduction therapy', 'level': 4, 'score': 0.4120317}, {'id': 'https://openalex.org/C55493867', 'wikidata': 'https://www.wikidata.org/wiki/Q7094', 'display_name': 'Biochemistry', 'level': 1, 'score': 0.37049606}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.3314411}, {'id': 'https://openalex.org/C104317684', 'wikidata': 'https://www.wikidata.org/wiki/Q7187', 'display_name': 'Gene', 'level': 2, 'score': 0.23201129}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.18007204}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.17852765}, {'id': 'https://openalex.org/C2779134260', 'wikidata': 'https://www.wikidata.org/wiki/Q12136', 'display_name': 'Disease', 'level': 2, 'score': 0.097672075}], 'mesh': [{'descriptor_ui': 'D056947', 'descriptor_name': 'Enzyme Replacement Therapy', 'qualifier_ui': 'Q000379', 'qualifier_name': 'methods', 'is_major_topic': True}, {'descriptor_ui': 'D000795', 'descriptor_name': 'Fabry Disease', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D009842', 'descriptor_name': 'Oligopeptides', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D011994', 'descriptor_name': 'Recombinant Proteins', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D000519', 'descriptor_name': 'alpha-Galactosidase', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D000818', 'descriptor_name': 'Animals', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D015153', 'descriptor_name': 'Blotting, Western', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D056947', 'descriptor_name': 'Enzyme Replacement Therapy', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000795', 'descriptor_name': 'Fabry Disease', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000795', 'descriptor_name': 'Fabry Disease', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}, {'descriptor_ui': 'D005455', 'descriptor_name': 'Fluorescent Antibody Technique', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D051379', 'descriptor_name': 'Mice', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D009842', 'descriptor_name': 'Oligopeptides', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D051381', 'descriptor_name': 'Rats', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011994', 'descriptor_name': 'Recombinant Proteins', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014281', 'descriptor_name': 'Trihexosylceramides', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014281', 'descriptor_name': 'Trihexosylceramides', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}, {'descriptor_ui': 'D000519', 'descriptor_name': 'alpha-Galactosidase', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 4, 'locations': [{'is_oa': True, 'landing_page_url': 'https://doi.org/10.1038/mt.2011.271', 'pdf_url': 'http://www.cell.com/article/S1525001616305366/pdf', 'source': {'id': 'https://openalex.org/S51596929', 'display_name': 'Molecular Therapy', 'issn_l': '1525-0016', 'issn': ['1525-0016', '1525-0024'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320990', 'host_organization_name': 'Elsevier BV', 'host_organization_lineage': ['https://openalex.org/P4310320990'], 'host_organization_lineage_names': ['Elsevier BV'], 'type': 'journal'}, 'license': 'cc-by-nc-nd', 'license_id': 'https://openalex.org/licenses/cc-by-nc-nd', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': True, 'landing_page_url': 'https://europepmc.org/articles/pmc3321591', 'pdf_url': 'https://europepmc.org/articles/pmc3321591?pdf=render', 'source': {'id': 'https://openalex.org/S4306400806', 'display_name': 'Europe PMC (PubMed Central)', 'issn_l': None, 'issn': None, 'is_oa': True, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1303153112', 'host_organization_name': 'European Bioinformatics Institute', 'host_organization_lineage': ['https://openalex.org/I1303153112'], 'host_organization_lineage_names': ['European Bioinformatics Institute'], 'type': 'repository'}, 'license': 'cc-by-nc-nd', 'license_id': 'https://openalex.org/licenses/cc-by-nc-nd', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': True, 'landing_page_url': 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3321591', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2764455111', 'display_name': 'PubMed Central', 'issn_l': None, 'issn': None, 'is_oa': True, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/22215019', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1038/mt.2011.271', 'pdf_url': 'http://www.cell.com/article/S1525001616305366/pdf', 'source': {'id': 'https://openalex.org/S51596929', 'display_name': 'Molecular Therapy', 'issn_l': '1525-0016', 'issn': ['1525-0016', '1525-0024'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320990', 'host_organization_name': 'Elsevier BV', 'host_organization_lineage': ['https://openalex.org/P4310320990'], 'host_organization_lineage_names': ['Elsevier BV'], 'type': 'journal'}, 'license': 'cc-by-nc-nd', 'license_id': 'https://openalex.org/licenses/cc-by-nc-nd', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'sustainable_development_goals': [], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 42, 'referenced_works': ['https://openalex.org/W1483242733', 'https://openalex.org/W1527172969', 'https://openalex.org/W1544162036', 'https://openalex.org/W1597854169', 'https://openalex.org/W1973112078', 'https://openalex.org/W1975365119', 'https://openalex.org/W1980743876', 'https://openalex.org/W1981632300', 'https://openalex.org/W1998963271', 'https://openalex.org/W2000106654', 'https://openalex.org/W2006892813', 'https://openalex.org/W2013758225', 'https://openalex.org/W2014122956', 'https://openalex.org/W2020681444', 'https://openalex.org/W2022356406', 'https://openalex.org/W2026507072', 'https://openalex.org/W2033079423', 'https://openalex.org/W2040321992', 'https://openalex.org/W2041953538', 'https://openalex.org/W2042318626', 'https://openalex.org/W2055750360', 'https://openalex.org/W2058754026', 'https://openalex.org/W2060701415', 'https://openalex.org/W2065957015', 'https://openalex.org/W2072830035', 'https://openalex.org/W2077459222', 'https://openalex.org/W2078005095', 'https://openalex.org/W2084764150', 'https://openalex.org/W2087017999', 'https://openalex.org/W2091164561', 'https://openalex.org/W2099739812', 'https://openalex.org/W2101510401', 'https://openalex.org/W2116806337', 'https://openalex.org/W2149357832', 'https://openalex.org/W2157481090', 'https://openalex.org/W2165425660', 'https://openalex.org/W2313827278', 'https://openalex.org/W2332862830', 'https://openalex.org/W2337160218', 'https://openalex.org/W3150370576', 'https://openalex.org/W3209992856', 'https://openalex.org/W4211146209'], 'related_works': ['https://openalex.org/W3172482025', 'https://openalex.org/W3043009539', 'https://openalex.org/W3041725937', 'https://openalex.org/W2886727630', 'https://openalex.org/W2531538514', 'https://openalex.org/W2084201369', 'https://openalex.org/W2058542530', 'https://openalex.org/W2034955397', 'https://openalex.org/W2024112896', 'https://openalex.org/W2021717101'], 'abstract_inverted_index': {'Fabry': [0, 55, 122], 'disease': [1], 'is': [2, 26, 50], 'an': [3], 'X-linked': [4], 'lysosomal': [5, 19], 'storage': [6], 'disorder': [7], '(LSD)': [8], 'caused': [9], 'by': [10, 28, 161], 'mutations': [11], 'in': [12, 112, 130, 164, 169], 'the': [13, 18, 32, 51, 80, 94, 155, 190], 'gene': [14], '(GLA)': [15], 'that': [16, 77], 'encodes': [17], 'hydrolase': [20], 'α-galactosidase': [21], 'A': [22, 42, 59, 99, 107, 126, 137, 146, 160, 175, 184], '(α-Gal': [23], 'A),': [24, 44], 'and': [25, 68, 102, 109, 117, 127, 138, 163, 177], 'characterized': [27], 'pathological': [29], 'accumulation': [30], 'of': [31, 38, 79, 97, 121, 150, 158, 194], 'substrate,': [33], 'globotriaosylceramide': [34], '(GL-3).': [35], 'Regular': [36], 'infusion': [37], 'recombinant': [39], 'human': [40], 'α-Gal': [41, 136, 174], '(rhα-Gal': [43], 'termed': [45], 'enzyme': [46], 'replacement': [47], 'therapy': [48], '(ERT),': [49], 'primary': [52], 'treatment': [53], 'for': [54], 'disease.': [56], 'However,': [57], 'rhα-Gal': [58, 98, 106, 125, 145, 159, 183, 197], 'has': [60], 'low': [61], 'physical': [62], 'stability,': [63], 'a': [64], 'short': [65], 'circulating': [66, 156], 'half-life,': [67], 'variable': [69], 'uptake': [70], 'into': [71], 'different': [72], 'disease-relevant': [73], 'tissues.': [74], 'We': [75], 'hypothesized': [76], 'coadministration': [78, 149], 'orally': [81], 'available,': [82], 'small': [83], 'molecule': [84], 'pharmacological': [85, 95], 'chaperone': [86], 'AT1001': [87, 104, 128, 151, 195], '(GR181413A,': [88], '1-deoxygalactonojirimycin,': [89], 'migalastat': [90], 'hydrochloride)': [91], 'may': [92], 'improve': [93], 'properties': [96], 'via': [100], 'binding': [101], 'stabilization.': [103], 'prevented': [105], 'denaturation': [108], 'activity': [110], 'loss': [111], 'vitro': [113], 'at': [114], 'neutral': [115], 'pH': [116], '37': [118], '°C.': [119], 'Coincubation': [120], 'fibroblasts': [123], 'with': [124], 'resulted': [129, 168], 'up': [131, 170], 'to': [132, 144, 152, 171], 'fourfold': [133, 178], 'higher': [134, 173], 'cellular': [135], '~30%': [139], 'greater': [140, 179], 'GL-3': [141, 180], 'reduction': [142, 181], 'compared': [143], 'alone.': [147, 185], 'Furthermore,': [148], 'rats': [153], 'increased': [154], 'half-life': [157], '>2.5-fold,': [162], 'GLA': [165], 'knockout': [166], 'mice': [167], 'fivefold': [172], 'levels': [176], 'than': [182], 'Collectively,': [186], 'these': [187], 'data': [188], 'highlight': [189], 'potentially': [191], 'beneficial': [192], 'effects': [193], 'on': [196], 'A,': [198], 'thus': [199], 'warranting': [200], 'clinical': [201], 'investigation.': [202]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2087176118', 'counts_by_year': [{'year': 2024, 'cited_by_count': 2}, {'year': 2023, 'cited_by_count': 4}, {'year': 2022, 'cited_by_count': 5}, {'year': 2021, 'cited_by_count': 3}, {'year': 2020, 'cited_by_count': 5}, {'year': 2019, 'cited_by_count': 6}, {'year': 2018, 'cited_by_count': 3}, {'year': 2017, 'cited_by_count': 3}, {'year': 2016, 'cited_by_count': 14}, {'year': 2015, 'cited_by_count': 8}, {'year': 2014, 'cited_by_count': 12}, {'year': 2013, 'cited_by_count': 14}, {'year': 2012, 'cited_by_count': 7}], 'updated_date': '2024-09-17T16:06:47.265121', 'created_date': '2016-06-24'}